SGS Implements PBMC Analysis for Early Phase Clinical Trials

Published on: 

Applied Clinical Trials

SGS, a life sciences, pharmaceutical, clinical, and bioanalytical contract solutions provider, announced that it has successfully implemented advanced techniques for the collection and use of peripheral blood mononuclear cells for early phase clinical trials at its Clinical Pharmacology Unit in Antwerp, Belgium.

Read the full release here.